Imperva Inc (NYSE:IMPV) insider Amichai Shulman sold 3,089 shares of the stock in a transaction on Monday, May 15th. The shares were sold at an average price of $48.70, for a total transaction of $150,434.30. Following the transaction, the insider now directly owns 100,151 shares in the company, valued at approximately $4,877,353.70. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Amichai Shulman also recently made the following trade(s):

  • On Monday, April 17th, Amichai Shulman sold 3,085 shares of Imperva stock. The shares were sold at an average price of $41.97, for a total transaction of $129,477.45.
  • On Wednesday, March 15th, Amichai Shulman sold 3,085 shares of Imperva stock. The stock was sold at an average price of $41.85, for a total transaction of $129,107.25.
  • On Wednesday, February 15th, Amichai Shulman sold 3,085 shares of Imperva stock. The stock was sold at an average price of $45.91, for a total transaction of $141,632.35.

Imperva Inc (NYSE:IMPV) traded up 0.20% during mid-day trading on Tuesday, reaching $49.10. 360,555 shares of the company’s stock were exchanged. The company’s 50-day moving average is $43.45 and its 200 day moving average is $41.05. Imperva Inc has a one year low of $33.01 and a one year high of $57.24. The firm’s market capitalization is $1.64 billion.

Imperva (NYSE:IMPV) last released its quarterly earnings results on Thursday, May 4th. The software maker reported ($0.29) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.62) by $0.33. The business had revenue of $72.31 million during the quarter, compared to analyst estimates of $68.16 million. Imperva had a negative net margin of 25.60% and a negative return on equity of 28.37%. The company’s quarterly revenue was up 21.0% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.25) earnings per share. Equities analysts predict that Imperva Inc will post $0.45 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Imperva (NYSE:IMPV)

ILLEGAL ACTIVITY NOTICE: “Imperva Inc (IMPV) Insider Sells $150,434.30 in Stock” was first published by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of US & international copyright laws. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/05/16/imperva-inc-impv-insider-sells-150434-30-in-stock.html.

A number of equities research analysts have issued reports on the stock. Evercore ISI reissued a “buy” rating and issued a $56.00 price target on shares of Imperva in a report on Monday. Zacks Investment Research lowered shares of Imperva from a “buy” rating to a “hold” rating in a report on Tuesday, May 9th. Imperial Capital reissued an “outperform” rating and issued a $57.00 price target (up previously from $55.00) on shares of Imperva in a report on Tuesday, May 9th. TheStreet raised shares of Imperva from a “d” rating to a “c” rating in a report on Thursday, May 4th. Finally, Oppenheimer Holdings Inc. reissued an “outperform” rating and issued a $55.00 price target on shares of Imperva in a report on Friday, February 10th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $48.42.

Institutional investors have recently made changes to their positions in the stock. Tudor Investment Corp ET AL bought a new position in shares of Imperva during the first quarter valued at approximately $363,000. Jane Street Group LLC bought a new position in shares of Imperva during the first quarter valued at approximately $224,000. Gotham Asset Management LLC bought a new position in shares of Imperva during the first quarter valued at approximately $358,000. Highbridge Capital Management LLC bought a new position in shares of Imperva during the first quarter valued at approximately $306,000. Finally, Ionic Capital Management LLC bought a new position in shares of Imperva during the first quarter valued at approximately $6,460,000. 92.72% of the stock is owned by hedge funds and other institutional investors.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

5 Day Chart for NYSE:IMPV

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.